黑料官网

header-logo
GettyImages-609179959-hero
headshot

Wael Saber, MD, MS

Professor

view physician profile

Locations

  • Froedtert Hospital

Specialties

  • Medical Oncology
  • Hematology

Languages

  • Arabic, English

Education

  • MD - Doctor of Medicine
  • MS -Master of Science

Biography

Dr. Wael Saber joined the faculty of 黑料官网 (黑料官网) in 2009 as an Associate Professor of Medicine in the Division of Hematology and Oncology. He is also an Assistant Scientific Director in the () at the 黑料官网, an internationally recognized research organization that focuses on outcomes related to Hematopoietic Stem Cell Transplantation (HCT).

Dr. Saber attended medical school at Ain Shams University in Egypt, and completed his internship and residency at the Cleveland Clinic Foundation. He completed an NIH T-32 research fellowship in Hematology at the University of Wisconsin in Madison. He holds a master’s degree in population health sciences from the University of Wisconsin.

Research Interests

Dr. Saber is an attending physician in the 黑料官网 adult HCT unit, with clinical interests in hematologic malignancies. His research interests are focused on outcomes related to HCT.

Publications

  • (de Lima M, Kebriaei P, Lanza F, Cho C, Popradi G, Kaur M, Zhang MJ, Zhang F, Shah R, Vandendries E, Asomaning K, Dorman S, Stelljes M, Marks DI, Saber W.) Am J Hematol. 2025 May;100(5):909-912 PMID: 39989181 PMCID: PMC11966346 SCOPUS ID: 2-s2.0-85218680599 02/24/2025

  • (Gadalla SM, Katki HA, Lai TP, Auer PL, Dagnall CL, Bupp C, Hutchinson AA, Anderson JJ, Mendez KJW, Spellman SR, Stewart V, Savage SA, Lee SJ, Levine JE, Saber W, Aviv A.) EBioMedicine. 2025 Apr;114:105641 PMID: 40058159 PMCID: PMC11930427 SCOPUS ID: 2-s2.0-86000327346 03/10/2025

  • (Sorror ML, Saber W, Logan BR, Geller NL, Bellach A, Kou J, Wood WA, McCarty J, Knight TG, Runaas L, Johnston LJ, Walston JD, Nakamura R, Jarrett L, Mishra A, Uberti J, Dahi PB, Saultz JN, McCurdy SR, Morris LE, Imus P, Hogan WJ, Nadiminti KVG, Bhatt VR, Olin RL, Maakaron J, Sobecks RM, Wall SA, Mattila D, Protz B, Devine SM, Horowitz MM, Artz AS.) Blood Adv. 2025 Mar 18 PMID: 40101246 03/18/2025

  • (Holtan SG, Bolaños-Meade J, Al Malki MM, Wu J, Kitko CL, Reshef R, Rezvani AR, Shaffer BC, Solh MM, Yao JM, Runaas L, Elmariah H, Larkin KT, El Jurdi N, Gooptu M, Loren AW, Hall AC, Alousi AM, Jamy O, Clark W, Kean L, Bhatt AS, Perales MA, Applegate K, Efebera YA, Leifer E, Jones RJ, Horowitz MM, Mattila D, Saber W, Hamadani M, Martens MJ.) J Clin Oncol. 2025 Mar 10;43(8):912-918 PMID: 39752608 SCOPUS ID: 2-s2.0-85214844948 01/03/2025

  • (Siegel SJ, DeWolf S, Schmalz J, Saber W, Dong J, Martens MJ, Logan B, Albanese A, Iovino L, Chen E, Kaminski J, Neuberg D, Hebert K, Keskula P, Zavistaski J, Steinberg L, Schichter I, Cagnin L, Hernandez V, Warren M, Applegate K, Bar M, Chhabra S, Choi SW, Clark W, Das S, Jenq R, Jones RJ, Levine JE, Murthy H, Rashidi A, Riches M, Sandhu K, Sung AD, Larkin K, Al Malki MM, Gooptu M, Elmariah H, Alousi A, Runaas L, Shaffer B, Rezvani A, El Jurdi N, Loren AW, Scheffey D, Sanders C, Hamadani M, Dudakov J, Bien S, Robins H, Horowitz M, Bolaños-Meade J, Holtan S, Bhatt AS, Perales MA, Kean LS.) medRxiv. 2025 Feb 26 PMID: 40061351 PMCID: PMC11888538 03/10/2025

  • (Dong J, Arsang-Jang S, Zhang T, Chen Z, Bolon YT, Spellman S, Urrutia R, Auer P, Saber W.) J Hematol Oncol. 2025 Feb 03;18(1):13 PMID: 39894808 PMCID: PMC11789331 SCOPUS ID: 2-s2.0-85217581264 02/03/2025

  • (Gui G, Ravindra N, Hegde PS, Andrew G, Mukherjee D, Wong Z, Auletta JJ, El Chaer F, Chen EC, Chen YB, Corner A, Devine SM, Iyer SG, Jimenez Jimenez AM, De Lima MJG, Litzow MR, Kebriaei P, Saber W, Spellman SR, Zeger SL, Page KM, Dillon LW, Hourigan CS.) Bone Marrow Transplant. 2025 Feb;60(2):154-160 PMID: 39506075 PMCID: PMC11810766 SCOPUS ID: 2-s2.0-85207014499 11/07/2024

  • (Toor AA, Horton M, Khalid H, Krieger E, Lai TP, Spellman SR, Levine JE, Saber W, Aviv A, Stewart V, Gadalla SM.) medRxiv. 2025 Jan 22 PMID: 39974130 PMCID: PMC11838954 02/20/2025

  • (de Lima M, Kebriaei P, Lanza F, Cho C, Popradi G, Kaur M, Zhang MJ, Zhang F, Shah R, Vandendries E, Asomaning K, Dorman S, Stelljes M, Marks DI, Saber W.) American Journal of Hematology. May 2025;100(5):909-912 SCOPUS ID: 2-s2.0-85218680599 05/01/2025

  • (Dong J, Zimmermann MT, Haque N, Arsang-Jang S, Saber W, Gai X, Urrutia R.) Transplantation Reports. February 2025;10(1) SCOPUS ID: 2-s2.0-85215105221 02/01/2025

  • (Dong J, Arsang-Jang S, Zhang T, Chen Z, Bolon YT, Spellman S, Urrutia R, Auer P, Saber W.) J Hematol Oncol. 2024 Nov 04;17(1):104 PMID: 39497145 PMCID: PMC11533675 SCOPUS ID: 2-s2.0-85208516411 11/05/2024

  • (Guru Murthy GS, Zhang T, Bolon YT, Spellman S, Dong J, Auer P, Saber W.) Biomarker Research. December 2024;12(1) SCOPUS ID: 2-s2.0-85182980987 12/01/2024

Publications of from the

© 2025 黑料官网.  All rights reserved.  | Terms and Privacy | Web Accessibility Statement

Non-Discrimination Statement
The 黑料官网 (黑料官网) is committed to fostering a diverse community of outstanding faculty, staff, and students, as well as ensuring equal educational opportunity, employment, and access to services, programs, and activities, without regard to an individual's race, color, national origin, religion, age, disability, sex, gender identity/expression, sexual orientation, marital status, pregnancy, predisposing genetic characteristic, or military status. Employees, students, applicants or other members of the 黑料官网 community (including but not limited to vendors, visitors, and guests) may not be subjected to harassment that is prohibited by law or treated adversely or retaliated against based upon a protected characteristic. 黑料官网’s policy as well as federal and state laws and regulations prohibit unlawful discrimination and harassment.

Notice of Compliance with Laws and Commitment to Civil Rights
The 黑料官网 is committed to full compliance with all applicable federal, state, and local laws and regulations in the pursuit of our missions. Consistent with recent federal guidance, we affirm our commitment to individual merit, fairness, and equal treatment in all aspects of academic and institutional decision-making. As part of this commitment, we are actively reviewing our policies and materials to ensure they align with federal nondiscrimination obligations.